Navigation Links
Kremers Urban Pharmaceuticals Inc. Announces Lipitor® Settlement Agreement
Date:11/18/2011

PRINCETON, N.J., Nov. 18, 2011 /PRNewswire/ -- Kremers Urban Pharmaceuticals Inc. today announced that it has entered into a settlement agreement which will resolve litigation related to Lipitor® Tablets, 10 mg, 20 mg, 40 mg, and 80 mg, known generically as Atorvastatin Calcium tablets.  

The terms of the agreement are confidential, and the agreement itself is subject to review by the U.S. Department of Justice and the Federal Trade Commission.

About Kremers Urban

Kremers Urban Pharmaceuticals Inc., a specialty generic drug manufacturer and subsidiary of Belgium-based UCB, is a pioneer in developing generic versions of pharmaceutical products that have a "high barrier to entry." The Company is moving to the forefront of delivering the tough solutions necessary to get complex products into the market. To learn more visit www.kremersurban.com.

For More Information Contact:

France Nivelle, Global Communications
+32 2 559 9178; france.nivelle@ucb.com

Antje Witte, Investor Relations
+32 2 559 9414; antje.witte@ucb.com


'/>"/>
SOURCE Kremers Urban Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Kremers Urban Pharmaceuticals Inc. Settles Concerta® Patent Litigation
2. Study Sheds Light on Young Suburban Heroin Users
3. NxStage Medical Founder and CEO Jeffrey Burbank Honored With Mass High Tech All-Star Award
4. CVS Caremark Showcases Workplace and Marketplace Diversity at 2011 National Urban League Conference
5. Surgical Care Affiliates Announces Agreement With Suburban Outpatient Surgery Center
6. NxStage Founder and CEO Jeffrey Burbank Named Ernst & Young Entrepreneur of the Year® 2011 New England Award Winner
7. Teach For America and the Amgen Foundation Renew Partnership to Improve Math and Science Education in Urban and Rural Schools
8. American Heart Association Rapid Access Journal Report: Implanted Monitor Accurately Detects Heart Rhythm Disturbances
9. Bionovos MF101 Shows Statistically Significant Improvement in Sleep Disturbance from Hot Flashes
10. Merrimack Pharmaceuticals Initiates Enrollment in Phase 2 Study of MM-121 in Combination with Erlotinib in Three Groups of Patients with Non-Small Cell Lung Cancer
11. Avanir Pharmaceuticals Announces EMA Acceptance of Marketing Authorization Application for NUEDEXTA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/12/2017)... , July 12, 2017  Eli Lilly and Company (NYSE: ... with generic companies to resolve pending patent litigation in the ... Virginia regarding the Cialis ® (tadalafil) unit ... April 26, 2020. As part of the agreement, Cialis exclusivity ... 27, 2018. "The unit dose patent for Cialis ...
(Date:7/11/2017)... Md. , July 11, 2017  The global ... estimated revenues of approximately $394.1 million in 2016.  Although ... trend of solid growth, in particular as a result ... clinical practice, and the recent introduction of a significant ... need for less-invasive testing of tumor biomarkers to guide ...
(Date:7/11/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) ( ... development of oral drug delivery systems, announced today that ... to schedule an End-of-Phase II meeting with Oramed for ... insulin capsule ORMD-0801 in the treatment of type 2 ... endpoints by indicating a statistically significant lowering of glucose ...
Breaking Medicine Technology:
(Date:7/24/2017)... ... July 24, 2017 , ... Axiad IDS , a leading provider of ... with WALLIX to expand its solution to help government contractors more quickly ... number of ways to address the authentication requirements within NIST SP800-171, but no ...
(Date:7/24/2017)... ... 24, 2017 , ... Anyone who uses scales know they have limits; a ... using that same scale to dispense medication. The first example is an issue of ... why it is important to have the right balance for the process. METTLER TOLEDO’s ...
(Date:7/24/2017)... ... ... A Southern California-based author has released a new book which details her ... them. “Forbidden Memories: A Memoir,” by author Michelle V. Madsen, highlights the author’s journey ... In “Memories,” readers get a firsthand look at what Michelle has been through in ...
(Date:7/24/2017)... VA (PRWEB) , ... July 24, 2017 , ... ... out how to change manufacturers future. , The agency is hammering out a ... Act, one of the farthest-ranging laws ever to affect FDA-regulated firms. The new ...
(Date:7/24/2017)... ... July 24, 2017 , ... “A Short Walk to the Mailbox”: a remarkable ... creation of published author, Ed Clark. Ed Clark is a church music director ... as a minister of music and worship leader for over fifty years. He ...
Breaking Medicine News(10 mins):